Gene Editing of CCR5 in Hematopoietic Stem Cells in a Nonhuman Primate Model of HIV/AIDS

被引：1
|
作者：
Peterson, Christopher W. [1 ]
Wang, Jianbin [2 ]
Polacino, Patricia [3 ]
Holmes, Michael C. [2 ]
Hu, Shiu-Lok [3 ,4 ]
Gregory, Philip D. [2 ]
Kiem, Hans-Peter [1 ,5 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Sangamo BioSci Inc, Richmond, CA USA
[3] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA
[4] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA
[5] Univ Washington, Seattle, WA 98195 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.4802.4802
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Intracellular RNASE Activity Limits the Efficiency of mRNA-Based Gene Editing in Nonhuman Primate Hematopoietic Stem and Progenitor Cells
    Peterson, Christopher W.
    Venkataraman, Rasika
    Reddy, Sowmya S.
    Einhaus, Teresa
    Radtke, Stefan
    Humbert, Olivier
    Kiem, Hans-Peter
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 105 - 105
  • [22] Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair
    Hematti, P
    Obrtlikova, P
    Kaufman, DS
    [J]. EXPERIMENTAL HEMATOLOGY, 2005, 33 (09) : 980 - 986
  • [23] Autologous Hematopoietic Stem Cells transplantation and genetic modification of CCR5 m303/m303 mutant patient for HIV/AIDS
    Esmaeilzadeh, Abdolreza
    Farshbaf, Alieh
    Erfanmanesh, Maryam
    [J]. MEDICAL HYPOTHESES, 2015, 84 (03) : 216 - 218
  • [24] Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV
    Almeida, Maria Joao
    Matos, Ana
    [J]. CURRENT HIV RESEARCH, 2019, 17 (05) : 306 - 323
  • [25] Adopting autologous hematopoietic stem cells with non-functional CCR5 and CXCR4 against HIV
    Y Lai
    [J]. Bone Marrow Transplantation, 2010, 45 : 770 - 771
  • [26] Adopting autologous hematopoietic stem cells with non-functional CCR5 and CXCR4 against HIV
    Lai, Y.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 (04) : 770 - 771
  • [27] Why CCR5 is Chosen as the Target for Stem Cell Gene Therapy for HIV Infection?
    Zhang, Jia
    Li, Alice Saint Sinoasia
    Kou, Xiaojin
    Xiao, Li
    Li, Ping
    He, Nongyue
    Li, Kai
    [J]. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2012, 12 (03) : 2045 - 2048
  • [28] Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing
    Knipping, Friederike
    Newby, Gregory A.
    Eide, Cindy R.
    McElroy, Amber N.
    Nielsen, Sarah C.
    Smith, Kyle
    Fang, Yongxing
    Cornu, Tatjana, I
    Costa, Caroline
    Gutierrez-Guerrero, Alejandra
    Bingea, Samuel P.
    Feser, Colby J.
    Steinbeck, Benjamin
    Hippen, Keli L.
    Blazar, Bruce R.
    McCaffrey, Anton
    Mussolino, Claudio
    Verhoeyen, Els
    Tolar, Jakub
    Liu, David R.
    Osborn, Mark J.
    [J]. MOLECULAR THERAPY, 2022, 30 (01) : 130 - 144
  • [29] In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model
    Hanazono, Y
    Nagashima, T
    Takatoku, M
    Shibata, H
    Ageyama, N
    Asano, T
    Ueda, Y
    Dunbar, CE
    Kume, A
    Terao, K
    Hasegawa, M
    Ozawa, K
    [J]. GENE THERAPY, 2002, 9 (16) : 1055 - 1064
  • [30] In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model
    Y Hanazono
    T Nagashima
    M Takatoku
    H Shibata
    N Ageyama
    T Asano
    Y Ueda
    CE Dunbar
    A Kume
    K Terao
    M Hasegawa
    K Ozawa
    [J]. Gene Therapy, 2002, 9 : 1055 - 1064
12345